Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Tianjin Pharmaceutical has upped its stake in Tianjin Pharmaceutical Group Finance Co., Ltd. (TPGF) from 15% to 30% by acquiring shares from Lisheng Pharmaceutical. To meet regulatory capital requirements, the shareholders of TPGF, including Tianjin Pharmaceutical, have agreed to double TPGF’s registered capital to RMB1 billion, with Tianjin Pharmaceutical contributing RMB150 million from internal resources. This move will maintain the company’s 30% shareholding in TPGF, while supporting its continued operation within regulatory guidelines.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
